Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2020 / N 3

Гормонозависимая бронхиальная астма: прошлое и настоящее
Т.Н. Молостова

References

1. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf Accessed 2021 Mar 24.
2. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2019. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf Accessed 2021 Mar 24.
3. Chuchalin AG, Khaltaev N, Аntonov N, Galkin DV, Manakov LG, Antonini P, Murphy M, Solodovnikov AG, Bousquet J, Pereira MHS, Demko IV. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. International Journal of Chronic Obstructive Pulmonary Disease 2014 Sep;9:963-74.
4. Russian Respiratory Society; Pediatric Respiratory Society. National program "Bronchial asthma in children. Treatment strategy and prevention". 4th ed., revised. Moskow: Orighinal-Maket; 2013. 182 p. (In Russian).
5. Bel EH. Severe asthma. Breath 2006 Dec;3(2):129-39.
6. Broder MS, Raimundo K, Ngai KM, Chang E, Griffin NM, Heaney LG. Cost and health care utilization in patients with asthma and high oral corticosteroid use. Annals of Allergy, Asthma & Immunology 2017;118(5):638-9.
7. Shaw DE, Sousa AR, Fowler SJ, Fleming LJ, Roberts G, Corfield J, Pandis I, Bansal AT, Bel EH, Auffray C, Compton CH, Bisgaard H, Bucchioni E, Caruso M, Chanez P, Dahlén B, Dahlen SE, Dyson K, Frey U, Geiser T, Gerhardsson de Verdier M, Gibeon D, Guo TK, Hashimoto S, Hedlin G, Jeyasingham E, Hekking PPW, Higenbottam T, Horváth I, Knox AJ, Krug N, Erpenbeck VJ, Larsson LX, Lazarinis N, Matthews JG, Middelveld R, Montuschi P, Musial J, Myles D, Pahus L, Sandström T, Seibold W, Singer F, Strandberg K, Vestbo J, Vissing N, von Garnier C, Adcock IM, Wagers S, Rowe A, Howarth P, Wagener AH, Djukanovic R, Sterk PJ, Chung KF; U-BIOPRED Study Group. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. The European Respiratory Journal 2015 Nov;46(5):1308-21.
8. Sergeyeva GR, Yemelyanov AV, Korovina OV, Znakhurenko AA, Leshenkova EV, Kozyreva LV, Asatiani N. Severe bronchial asthma: characteristics of patients in clinical practice. Therapeutic Archive 2015;87(12):1226-31 (In Russian).
9. Chuchalin AG. Bronchial asthma. Moscow: Meditsina; 1985. 160 p. (In Russian).
10. Drozhzhev ME. Clinical and pathogenetic features of hormone-dependent bronchial asthma in children [Dissertation for the Degree of Candidate of Medical Sciences]. Moscow, 1993.
11. Israel E, Reddel HK. Severe and difficult-to-treat asthma in adults. The New England Journal of Medicine 2017 Sep;377(10):965-76.
12. Barnes P. Glucocorticosteroids. Handbook of Experimental Pharmacology 2017;237:93-115.
13. Barnes PJ. Mechanism of action of glucocorticoids in asthma. American Journal of Respiratory and Critical Care Medicine 1996 Aug;154(2 Pt 2):S21-7.
14. Barnes PJ. Glucocorticosteroids: current and future directions. British Journal of Pharmacology 2011 May;163(1):29-43.
15. Global Initiative for Asthma. Diagnosis and management of difficult-to-treat and severe asthma. 2019. Available from: https://ginasthma.org/severeasthma/ Accessed 2021 Mar 24.
16. Nenasheva NM, Astafyeva NG. Bronchial asthma: pathogenesis and phenotypes. In: Respiratory medicine: manual. 3 vol. set. 2nd ed., revised. Chuchalin AG, editor. Vol. 1. Moscow: Litterra; 2017 (In Russian).
17. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nature Medicine 2012 May;18(5):716-25.
18. Robinson D, Humbert M, Buhl R, Cruz AA, Inoue H, Korom S, Hanania NA, Nair P. Revisiting type 2-high and type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clinical & Experimental Allergy 2017 Feb;47(2):161-75.
19. Fahy JV. Type 2 inflammation in asthma – present in most, absent in many. Nature Reviews. Immunology 2015 Jan;15(1):57-65.
20. Agustí A, Bafadhel M, Beasley R, Bel EH, Faner R, Gibson PG, Louis R, McDonald VM, Sterk PJ, Thomas M, Vogelmeier C, Pavord ID, on behalf of all participants in the seminar. Precision medicine in airway diseases: moving to clinical practice. The European Respiratory Journal 2017 Oct;50(4):1701655.
21. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AA, Ellwanger A, Koth LL, Arron JR, Fahy JV. T-helper type 2-driven inflammation defines major subphenotypes of asthma. American Journal of Respiratory and Critical Care Medicine 2009 Sep;180(5):388-95.
22. Gandhi NA, Bennett BL, Graham NM, Pirozzi G, Stahl N, Yancopoulos GD. Targeting key proximal drivers of type 2 inflammation in disease. Nature Reviews. Drug Discovery 2016 Jan;15(1):35-50.
23. Pavord ID. Oral corticosteroid-dependent asthma: current knowledge and future needs. Current Opinion in Pulmonary Medicine 2019 Jan;25(1):51-8.
24. Chung F, Fabbri LM. Severe therapy-resistant asthma. In: Asthma. European Respiratory Monograph. Sheffield, UK: ERS; 2003.
25. Ministry of Healthcare of the Russian Federation. Clinical recommendations. Bronchial asthma. ICD 10: J. 45, J. 46. Year of approval 2019. Available from: http://spulmo.ru Accessed 2021 Mar 24. (In Russian).
26. Fassakhov RS, Reshetnikova ID. Steroid-dependent bronchial asthma: recommendations for management of patients and reducing the dose of systemic glucocorticosteroids. Pulmonologiya 2010;6:98-103 (In Russian).
27. Sanofi. Path to long-term control of T2-asthma (Type-2 asthma). Effective Pharmacotherapy. Allergology and Immunology 2020;16(8):66-78 (In Russian).
28. State Register of Medicines. Instructions for medical use of Dupixent drug. Available from: http://grls.rosminzdrav.ru/ Accessed 2021 Mar 24.
29. Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. The New England Journal of Medicine 2018 Jun;378(26):2486-96.
30. Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, Zhu H, Hamilton JD, Swanson BN, Khan A, Chao J, Staudinger H, Pirozzi G, Antoni C, Amin N, Ruddy M, Akinlade B, Graham NMH, Stahl N, Yancopoulos GD, Teper A. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. The New England Journal of Medicine 2018 Jun;378(26):2475-85.
31. Avdeyev SN. Treatment of severe bronchial asthma: current options and new prospects. Effective Pharmacotherapy. Pulmonology and Otorhinolaryngology 2019;15(27):50-8 (In Russian).
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]